Heart surgery study seeks goldilocks dose for bleeding drug
NCT ID NCT07164300
Summary
This study aims to find the best dose of a common drug (tranexamic acid) used to control bleeding during heart surgery. Researchers will compare three different dosing plans in 150 patients to see which one works longest to prevent bleeding problems while minimizing side effects like seizures. The goal is to gather evidence for a standard, safer dosing guideline.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVERSE DRUG EVENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Ioannina
RECRUITINGIoannina, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.